
In 2023, QualityMetric (QM) became an IQVIA business. This further enabled us to provide clinical outcome assessment (COA) licensing in addition to leveraging our combined innovative technology solutions and scientific expertise. Since our full integration into IQVIA will soon be complete, it is time to retire the QM brand.
As we remain committed to our same quality licensing and services, we invite you to find the legacy QM COAs you know, in addition to the other 160+ COA offerings on IQVIA's COA Marketplace.
Our research team is highly experienced in developing, modifying, and validating patient-reported outcome (PRO) measures for diverse healthcare and life science market needs, ensuring we meet each client’s specific purpose.
Our qualitative research team is highly skilled in conducting concept elicitation interviews with patients, key opinion leaders, and clinical experts to identify and develop key concepts best suited for measuring your patients’ disease, treatment experience and quality of life.
In addition, the team has expertise in conducting cognitive debriefing interviews to ensure that the items, instructions, response choices, and other aspects of newly developed instruments or modifications to items of existing instruments are well understood by patients and other key stakeholders, such as caregivers. Leveraging decades of regulatory insight, our qualitative approach to instrument development is aligned with specific regulatory guidelines and industry best practices.
Our quantitative research team has decades of experience in the application of both classical test theory and modern psychometric methods in the development and evaluation of new or existing PRO instruments.
We can apply these same best practices for instruments being developed for clinical use or other applications that do not require meeting regulatory guidelines.